
1. vaccine. 2008 aug 19;26 suppl 12:m80-8. doi: 10.1016/j.vaccine.2008.05.041.

human papillomavirus cervical cancer australasia oceania:
risk-factors, epidemiology prevention.

garland sm(1), brotherton jm, skinner sr, pitts m, saville m, mola g, jones rw.

author information: 
(1)department microbiology infectious diseases, royal women's
hospital, melbourne, victoria, australia. sue.garland@thewomens.org.au

the region encompassing australasia oceania, including australia, new
zealand, fiji papua new guinea, diverse one respect ethnicities,
cultures behaviours. includes countries comprehensive cervical
cytology screening programmes credited significant reductions
in cervical cancer incidence mortality, countries prevention
programmes significantly higher incidence mortality. elsewhere 
world, human papillomavirus (hpv)-16 18 commonest high-risk types,
with highest rates women 25 years age. two high-risk hpv
types found frequently cervical cancers high-grade dysplasias,
although minimal data many countries oceania. april 2007,
australia became first country worldwide commence government funded
universal hpv vaccine programme. school-based programme targets 12-year old
females ongoing schedule, catch-up programme 26 years age, 
to completed mid-2009. vaccine introduction comprehensively rolled
out, around 75% uptake complete vaccine schedule among school-girls
in first year initiative. represents successful model for
other countries. present data cervical cancer, risk factors prevention 
strategies, including epidemiology hpv hpv vaccine strategies.

doi: 10.1016/j.vaccine.2008.05.041 
pmid: 18945417  [indexed medline]

